Growth was evaluated in 11 HM‐fed infants with FAODs (Table S4, n = 1 MCAD deficiency, n = 3 LCHAD deficiency, n = 1 VLCAD deficiency, n = 1 CACT deficiency, n = 1 CPT II deficiency, and n = 4 LCHAD/VLCAD deficiency) from four studies (two conference abstracts). This evidence concerns the gene CPT2 and carnitine-acylcarnitine translocase deficiency.